Our vaccines portfolio
Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
Bexsero
Meningococcal group B vaccines (rDNA, component, adsorbed)
Boostrix
Diphtheria, tetanus and pertussis
(acellular, component) vaccine
(adsorbed, reduced antigen(s) content)
Engerix B 20mcg (Adult)
Hepatitis B (rDNA) vaccine (adsorbed) (HBV)
Fendrix
Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)
Havrix Monodose
Hepatitis A vaccine
(inactivated, adsorbed)
Havrix Junior Monodose
Hepatitis A vaccine
(inactivated, adsorbed)
Hiberix
Haemophilus Type b (Hib) vaccine
Infanrix Hexa
Diphtheria (D), tetanus (T),
pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)
Menjugate
Meningococcal group C conjugate vaccine
Priorix
Measles, Mumps and Rubella vaccine (live)
rotavirus vaccine, live
Herpes zoster vaccine (recombinant, adjuvanted)
Twinrix (Adult)
Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Arexvy, Bexsero, Boostrix, Engerix B, Fendrix, Havrix, Hiberix, Infanrix Hexa, Menitorix, Menjugate, Priorix, Rotarix, Shingrix and Twinrix are registered trademarks of the GlaxoSmithKline Group of Companies.